MR [Mindray Medical International] 20-F: (Original Filing)

[Table ofntents Page INTRODUCTION 1 PARTI 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THEMPANY 23 ITEM 4A. UNRESOLVED STAFFMMENTS 42 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS] [LIST OF SUBSIDIARIES Mindray (UK)Limited,orporated in the United Kingdom Mindray Research and Development Limited,orporated in the British Virgin Islands Mindray Global Limited,orporated in the British Virgin Islands Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Beijing Shen Mindray Medical Electronics Technology Research Instituteorporated in the Peoples Republic of China] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Ronald Ede, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION Xu Hang Chairman and-Chief Executive Officer Li Xiting Director, President and-Chief Executive Officer Ronald Ede Director, Chief Financial Officer EX-13.1 h04675exv13w1.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No. 333-169440) of Mindray Medical International Limited of our reportted April8, 2011 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form 20-F. Wesonsent to the reference to]

MR [Mindray Medical International] 20-F: Table ofntents Page INTRODUCTION 1 PARTI 2 ITEM

[Table ofntents Page INTRODUCTION 1 PARTI 2 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 2 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 2 ITEM 3. KEY INFORMATION 2 ITEM 4. INFORMATION ON THEMPANY 23 ITEM 4A. UNRESOLVED STAFFMMENTS 42 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS] [LIST OF SUBSIDIARIES Mindray (UK)Limited,orporated in the United Kingdom Mindray Research and Development Limited,orporated in the British Virgin Islands Mindray Global Limited,orporated in the British Virgin Islands Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Beijing Shen Mindray Medical Electronics Technology Research Instituteorporated in the Peoples Republic of China] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Ronald Ede, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION Xu Hang Chairman and-Chief Executive Officer Li Xiting Director, President and-Chief Executive Officer Ronald Ede Director, Chief Financial Officer EX-13.1 h04675exv13w1.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No. 333-169440) of Mindray Medical International Limited of our reportted April8, 2011 relating to the financial statements and the effectiveness of internalntrol over financial reporting, which appears in this Form 20-F. Wesonsent to the reference to]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Appoints Mr. Jie Liu as Chief Financial Officer Mr. Ronald Ede Will Remain With Mindray as a Director SHENZHEN, China, March 18 /PRNewswire-Asia-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu as Chief Financial Officer (CFO) of the Company effective as of]

MR [Mindray Medical International] 6-K: Mindray Appoints Mr. Jie Liu as Chief Financial

[Mindray Appoints Mr. Jie Liu as Chief Financial Officer Mr. Ronald Ede Will Remain With Mindray as a Director SHENZHEN, China, March 18 /PRNewswire-Asia-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu as Chief Financial Officer (CFO) of the Company effective as of]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald Ede Will Remain With Mindray a Director SHENZHEN, China, March18 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu Chief Financial Officer (CFO)of thempany effective of April 30, 2011, succeeding Mr.Ronald]

MR [Mindray Medical International] 6-K: Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald

[Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald Ede Will Remain With Mindray a Director SHENZHEN, China, March18 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu Chief Financial Officer (CFO)of thempany effective of April 30, 2011, succeeding Mr.Ronald]

MR [Mindray Medical International] 6-K: Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald

[Mindray Appoints Mr.Jie Liu Chief Financial Officer Mr.Ronald Ede Will Remain With Mindray a Director SHENZHEN, China, March18 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Jie Liu Chief Financial Officer (CFO)of thempany effective of April 30, 2011, succeeding Mr.Ronald]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2010 Fourth Quarter and Full Year Results SHENZHEN, China, Feb. 28, 2011 /PRNewswire via COMTEX/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2010. Highlights for Fourth Quarter and Full Year 2010]

By | 2016-03-04T09:01:53+00:00 February 28th, 2011|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces 2010 Fourth Quarter and Full Year

[Mindray Announces 2010 Fourth Quarter and Full Year Results SHENZHEN, China, Feb. 28, 2011 /PRNewswire via COMTEX/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2010. Highlights for Fourth Quarter and Full Year 2010]

By | 2016-03-04T09:04:15+00:00 February 28th, 2011|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2010 Fourth Quarter and Full Year Results SHENZHEN, China, Feb. 28, 2011 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2010.]

By | 2016-02-08T05:53:34+00:00 February 28th, 2011|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar